SAM #ARPA-H-SOL-26-160

ARPA-H FASTPASS Solicitation for AI-enabled Pharmaceutical Screening System

ARPA-H, part of the National Institutes of Health under the Department of Health and Human Services, is launching the FASTPASS program to enhance pharmaceutical supply chain security. - Government Buyer: - Advanced Research Projects Agency for Health (ARPA-H), NIH, HHS - Program Objective: - Develop a near real-time, non-destructive, AI/ML-enabled system for screening pharmaceutical products and inputs through packaging at ports of entry and supply-chain nodes - Focus on rapid detection of contamination, adulteration, and formulation variability without opening packages - Technical Requirements: - System must work across six major packaging types - Integration of multiple sensing modalities (e.g., nuclear magnetic resonance, Raman spectroscopy, x-ray fluorescence, hyperspectral imaging) - Advanced machine learning models for data interpretation, specificity, noise reduction, self-calibration, and automated sample positioning - Program Structure: - Three 18-month phases (total 54 months) with aggressive milestones and down-selections - Encourages teaming between sensor developers and computational modelers - No specific OEMs, vendors, product models, part numbers, or quantities are named - Unique Requirements: - AI integration, non-destructive through-packaging screening, multi-modal sensing, and rapid supply chain assessment

Description

The Advanced Research Projects Agency for Health (ARPA-H) Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and SupplieS (FASTPASS) program aims to develop a near real-time, non-destructive, AI-enabled system for screening pharmaceutical products and inputs through their packaging at ports of entry and other supply-chain nodes.

Interested parties are invited to review the attached FASTPASS Innovative Solutions Opening, ARPA-H-SOL-26-160.

View original listing